Navigation Links
New drug combination therapy developed to treat leukemia
Date:4/17/2013

A new, pre-clinical study by researchers at Virginia Commonwealth University Massey Cancer Center suggests that a novel drug combination could lead to profound leukemia cell death by disrupting the function of two major pro-survival proteins. The effectiveness of the therapy lies in its ability to target a pro-survival cell signaling pathway known as PI3K/AKT/mTOR, upon which the leukemia cells have become dependent.

In the study, published in the journal Cancer Research, researchers combined the drug ABT-737 with another agent BEZ235. ABT-737 targets proteins known as B-cell lymphoma 2 (Bcl-2) and Bcl-xL, which prevent apoptosis, a form of cell suicide, in cancer cells. BEZ235 directly inhibits the PI3K/AKT/mTOR pathway, and as a result, reduces the expression of another anti-apoptotic protein known as Mcl-1, which is not targeted by ABT-737. Among their many functions, signaling pathways regulate biological processes required for cellular survival. The PI3K/AKT/mTOR pathway helps keep apoptosis in check, in part, by controlling the production of Mcl-1. However, the pathway can become dysregulated in cancer, and in so doing, contribute to uncontrolled tumor growth and resistance to conventional cancer therapies. It is activated in 50 to 80 percent of patients with acute myelogenous leukemia (AML), and in some, but not all cases, is associated with genetic mutations. Significantly, disabling both anti-apoptotic proteins, Bcl-2 and Bcl-xL, in conjunction with Mcl-1, caused profound cell death of leukemia cells in the test tube as well as in animal models of AML.

"This study builds on many years of work in our laboratory investigating the mechanisms that regulate apoptosis in human leukemia cells. To the best of our knowledge, it is the first to raise the possibility that activation of the P13K/AKT/mTOR pathway, rather than genetic mutations within the pathway, may represent the best predictor of leukemia cell responses to these targete
'/>"/>

Contact: Alaina Farrish
akfarrish@vcu.edu
804-628-4578
Virginia Commonwealth University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Immunotherapy for elderly cancer patients finds new promise in drug combination
2. Combination of 2 drugs reverses liver tumors
3. Cancer vaccine combination therapy shows survival benefit in breast cancer
4. Discovery suggests new combination therapy strategy for basal-like breast cancers
5. Moffitt Cancer Center researchers test drug combinations to prevent graft vs. host disease
6. BUSM in vitro study identifies potential combination therapy for breast cancer
7. DNDi and Cipla to develop 4-in-1 pediatric antiretroviral drug combination
8. Combination peptide therapies might offer more effective, less toxic cancer treatment
9. Drug combination against NRAS-mutant melanoma discovered
10. Combination treatment may improve survival of breast cancer patients with brain metastases
11. Scientists test 5,000 combinations of 100 existing cancer drugs to find more effective treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... York, NY (PRWEB) May 29, 2015 ... USA Today, with a circulation of approximately 250,000 and ... distributed nationally, through a vast social media strategy, and ... outlets. To explore the digital version of the campaign, ... cover of the print publication. Inside, the actress, model ...
(Date:5/29/2015)... May 29, 2015 OncLive proudly announces ... dozen medical pioneers recognized by a panel of eminent ... of cancer treatment. Honorees will be introduced and celebrated ... Award Ceremony, held 8:30-11:00 p.m. CDT at The Chicago ... honorees are being recognized for groundbreaking accomplishments, in fields ...
(Date:5/29/2015)... CA (PRWEB) May 29, 2015 Oaksterdam University, the ... June, this time to host its popular and highly demanded ... 14, and 15 from 10:00 am to 5:30 pm each day. ... Cannabis Job Fair will be held on June 14 from ... Fair will be held at the Plaza Hotel & Casino in ...
(Date:5/29/2015)... 29, 2015 Designed with the versatile ... to create an all new, exclusive line of supplementation ... with the latest and greatest, high impact, result driven ... be effective. The 24/7 Series can be used by ... even the casual fitness enthusiasts. There are no stimulant ...
(Date:5/29/2015)... MN (PRWEB) May 29, 2015 As ... Patio and Metro series outdoor saunas have increased in ... landscaping projects, and work at summer cottages. While ... piqued interest in summer projects a few weeks earlier ... suburban communities with smaller lot sizes tend to prefer ...
Breaking Medicine News(10 mins):Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 2Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 3Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 4Health News:Oaksterdam University to Host Educational Cannabis Seminars and Job Fair in Las Vegas June 12 to 15; Training For Those Wanting To Work in Legal Cannabis Industry 2Health News:Oaksterdam University to Host Educational Cannabis Seminars and Job Fair in Las Vegas June 12 to 15; Training For Those Wanting To Work in Legal Cannabis Industry 3Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 2Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 3Health News:As Summer Approaches, Finnleo Notes Increased Interest in Patio and Metro Outdoor Saunas 2
... GMPs and adverse event reportingWASHINGTON, March 2 ... Accountability Office (GAO) of a report on the ... Products Association (NPA) released the following statement from ... Association appreciates having the opportunity to be included ...
... Commission wildlife biologists continue to monitor bat hibernacula, the ... or dying from White Nose Syndrome (WNS) has risen ... Carbondale, Lackawanna County; an abandoned mine near Shickshinny, Luzerne ... and Seawra Cave in Mifflin County."We continue to receive ...
... Increases 72% from Prior YearDUBLIN, Calif., March 2 ... company dedicated to the discovery and development of novel ... quarter and year ended December 31, 2008. The Company ... of $2.6 million, or $0.04 per share, compared with ...
... March 2 Align Technology, Inc. (Nasdaq: ... of Invisalign Teen(TM) for non-adult, comprehensive orthodontic treatment. ... and demonstrated effectiveness of the Invisalign(R) system, with ... of permanent teeth, and root-movement control - issues ...
... HOLLYWOOD, Calif., March 2 IPC The Hospitalist Company, Inc. (Nasdaq: ... today announced financial results for the fourth quarter and full year ... , Net revenue ... area net revenue growth of 19% , ...
... and T-shirts are likely to drink more or become binge ... All those T-shirts, hats and other items promoting alcoholic beverages ... fashion statement. , , Teens who own such merchandise are ... new study contends. , The Dartmouth scientists who did the ...
Cached Medicine News:Health News:Natural Products Association Comments on New GAO Report on Regulation of Dietary Supplements 2Health News:WNS Identified at Six Sites in Pennsylvania 2Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 2Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 3Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 4Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 5Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 6Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 7Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 8Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 9Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 10Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 11Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 12Health News:Align Technology Announces International Availability of Invisalign Teen(TM) 2Health News:Align Technology Announces International Availability of Invisalign Teen(TM) 3Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 2Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 3Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 4Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 5Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 6Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 7Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 8Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 9Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 10Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 11Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 12Health News:Alcohol-Branded Apparel Linked to Adolescent Drinking 2Health News:Alcohol-Branded Apparel Linked to Adolescent Drinking 3Health News:Alcohol-Branded Apparel Linked to Adolescent Drinking 4
(Date:5/28/2015)... 2015 Research and ... of Jain PharmaBiotech,s new report  "RNAi - ... offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ... involves the use of double stranded RNA ... is processed into short 21-23 nucleotide RNAs ...
(Date:5/28/2015)... 28, 2015 Henry Schein , ... of health care products and services to office-based ... its customers that the Henry Schein Disaster Relief ... who experience operational, logistical or financial issues as ... South Central region of the U.S. The toll-free ...
(Date:5/28/2015)... CENTENNIAL, Colo. , May 28, 2015 /PRNewswire-USNewswire/ ... largest providers of cartilage, cellular, bone, skin and ... wound care to advance patient healing, today announced ... allograft, has been moved to the high-cost reimbursement ... our allografts reach doctors and their patients," said ...
Breaking Medicine Technology:Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 2Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 3Henry Schein Disaster Relief Hotline Is Open To Support Customers Affected By Storms In South Central, U.S. 2Henry Schein Disaster Relief Hotline Is Open To Support Customers Affected By Storms In South Central, U.S. 3AlloSource Announces Milestone In Reimbursement For AlloWrap DS 2
... Pharmaceuticals Inc.,(Nasdaq: TRBN ) today announced that ... ), has exercised its option under the terms ... research period for an,additional one-year period through Dec. ... extension, Wyeth,s obligations to Trubion include,collaboration research funding ...
... Community Oncology,Research Network(TM) (ACORN) will be showcasing ... PACE(TM) PRO System; and,proprietary oncology-focused data warehouse ... in Boston, MA., (Logo: http://www.newscom.com/cgi-bin/prnh/20071112/CLM151LOGO ... company announced its Contract Research Organization,(CRO) exceeded ...
Cached Medicine Technology:Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration 2Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration 3ACORN Showcases Oncology CRO, EDC, PRO and Data Warehouse at 44th Annual DIA Meeting 2
Codman periosteal elevators, sharp, length 8" (203 mm), blade width 3/16" (5 mm)....
Iowa University periosteal elevator, blade width 11/16" (17 mm), length 7 1/4" (184 mm)....
Cushing periosteal elevators, rounded edge, sharp, wide, blade width 5/8" (16 mm), length 7 1/4" (184 mm)....
Lederer periosteal elevators....
Medicine Products: